APR 02, 2020 2:30 PM PDT

Opportunities for using PacBio Long-read Sequencing for COVID-19 Research

Sponsored by: PacBio
C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

Scientists worldwide are actively working to tame the COVID-19 pandemic by developing therapies for patients with severe disease and a vaccine to stem transmission. Accomplishing these two goals will require high resolution genetic information on both the SARS-Cov-2 virus and the host response to infection, beyond what suffices for diagnostic testing.

PacBio highly accurate long-read sequencing data is one tool scientists can use in their COVID-19 research. PacBio sequencing is unique in that it produces HiFi reads that are both long (up to 15 kb) and have very high base-level accuracy (>99.9%). These qualities are advantageous for applications that require phasing of SNVs across DNA amplicons and for resolving individual variants within complex populations of highly similar sequences. For example, in order to develop a broadly efficacious therapeutic or vaccine, scientists will need to understand how SARS-CoV-2 evolves within a host, over time in a community, and across geographic regions. An examination of currently public SARS-CoV-2 genomes shows how challenging getting high quality data can be with other sequencing approaches. Similarly, when mining the immune repertoire of recovered patients for therapeutics, researchers will need accurate and complete information on B cell receptors that can carry SNVs and indels along the entire length of the variable region. Furthermore, PacBio sequencing can directly detect and phase the germline IGH locus from which B cell receptors are derived, allowing researchers to connect phenotype to genotype without inference. In this presentation, we will discuss what PacBio sequencing can offer COVID-19 researchers as they strive to understand the biology underlying this global pandemic.

Learning Objectives:

1. Understanding how highly accurate long reads can be used to obtain high quality SARS-CoV-2 genomes with no gaps, and how this connects to virus research goals

2. Understand how highly accurate long reads can be used to understand the host immune response to SARS-CoV-2 infection.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
Loading Comments...
Show Resources